European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

11th EFIM Day

Submitted by Aneta on 21 October 2026 - 14:47

The 11th edition of the EFIM Day took place in Brussels on Friday, 16 October gathering representatives of EFIM National Societies, EFIM Executive Committee members, Working Group Chairs, Young Internists, and invited guests from across Europe for discussions on the future of Internal Medicine and the work of EFIM. A total of approximately 46 participants representing 26 national societies, EFIM Executive Committee, and invited speakers attended the meeting in Brussels.

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 15:52

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 15:36

Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Date of authorisation: 09/01/2020, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 15:35

Human medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Date of authorisation: 09/01/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Tosmova (previously Tocilizumab STADA and Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 15:30

Human medicines European public assessment report (EPAR): Tosmova (previously Tocilizumab STADA and Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 15:15

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 20 October 2026 - 14:36

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 13, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More